坐骨神経痛治療市場は、2022年から2027年の間に30億8,908万米ドル成長し、予測期間中に4.83%のCAGRで加速すると予測されています。坐骨神経痛治療市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
	このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。この市場は、坐骨神経痛に対する意識の高まり、坐骨神経痛の危険因子の有病率の増加、パイプライン医薬品に対する規制の支援によって牽引されています。
	この調査は、クロニジンマイクロペレット硬膜外注射の開発が、今後数年間の坐骨神経痛治療市場の成長を促進する主な理由の1つであることを特定しています。 また、坐骨神経痛の研究資金の増加と坐骨神経痛治療のための理学療法への意識の高まりは、市場での大きな需要につながるでしょう。
	この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
	このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
								
						目次
						
	Table of Contents
	1 Executive Summary
	
	1.1 Market overview
	Exhibit 01: Executive Summary - Chart on Market Overview
	Exhibit 02: Executive Summary - Data Table on Market Overview
	Exhibit 03: Executive Summary - Chart on Global Market Characteristics
	Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
	Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
	Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
	Exhibit 07: Executive Summary - Chart on Incremental Growth
	Exhibit 08: Executive Summary - Data Table on Incremental Growth
	Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
	2 Market Landscape
	
	2.1 Market ecosystem
	Exhibit 10: Parent market
	Exhibit 11: Market Characteristics
	3 Market Sizing
	
	3.1 Market definition
	Exhibit 12: Offerings of vendors included in the market definition
	3.2 Market segment analysis
	Exhibit 13: Market segments
	3.3 Market size 2022
	3.4 Market outlook: Forecast for 2022-2027
	Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
	Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
	Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
	Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
	4 Historic Market Size
	
	4.1 Global Sciatica Treatment Market 2023-2027 2017 - 2021
	Exhibit 18: Historic Market Size - Data Table on global sciatica treatment market 2023-2027 2017 - 2021 ($ billion)
	4.2 End-user Segment Analysis 2017 - 2021
	Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
	4.3 Product Segment Analysis 2017 - 2021
	Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
	4.4 Geography Segment Analysis 2017 - 2021
	Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
	4.5 Country Segment Analysis 2017 - 2021
	Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
	5 Five Forces Analysis
	
	5.1 Five forces summary
	Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
	5.2 Bargaining power of buyers
	Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
	5.3 Bargaining power of suppliers
	Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
	5.4 Threat of new entrants
	Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
	5.5 Threat of substitutes
	Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
	5.6 Threat of rivalry
	Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
	5.7 Market condition
	Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
	6 Market Segmentation by End-user
	
	6.1 Market segments
	Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
	Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
	6.2 Comparison by End-user
	Exhibit 32: Chart on Comparison by End-user
	Exhibit 33: Data Table on Comparison by End-user
	6.3 Hospital - Market size and forecast 2022-2027
	Exhibit 34: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
	Exhibit 35: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
	Exhibit 36: Chart on Hospital - Year-over-year growth 2022-2027 (%)
	Exhibit 37: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
	6.4 Clinics - Market size and forecast 2022-2027
	Exhibit 38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
	Exhibit 39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
	Exhibit 40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
	Exhibit 41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
	6.5 Others - Market size and forecast 2022-2027
	Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
	Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
	Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
	Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
	6.6 Market opportunity by End-user
	Exhibit 46: Market opportunity by End-user ($ million)
	Exhibit 47: Data Table on Market opportunity by End-user ($ million)
	7 Market Segmentation by Product
	
	7.1 Market segments
	Exhibit 48: Chart on Product - Market share 2022-2027 (%)
	Exhibit 49: Data Table on Product - Market share 2022-2027 (%)
	7.2 Comparison by Product
	Exhibit 50: Chart on Comparison by Product
	Exhibit 51: Data Table on Comparison by Product
	7.3 Non-surgical treatment - Market size and forecast 2022-2027
	Exhibit 52: Chart on Non-surgical treatment - Market size and forecast 2022-2027 ($ million)
	Exhibit 53: Data Table on Non-surgical treatment - Market size and forecast 2022-2027 ($ million)
	Exhibit 54: Chart on Non-surgical treatment - Year-over-year growth 2022-2027 (%)
	Exhibit 55: Data Table on Non-surgical treatment - Year-over-year growth 2022-2027 (%)
	7.4 Surgical treatment - Market size and forecast 2022-2027
	Exhibit 56: Chart on Surgical treatment - Market size and forecast 2022-2027 ($ million)
	Exhibit 57: Data Table on Surgical treatment - Market size and forecast 2022-2027 ($ million)
	Exhibit 58: Chart on Surgical treatment - Year-over-year growth 2022-2027 (%)
	Exhibit 59: Data Table on Surgical treatment - Year-over-year growth 2022-2027 (%)
	7.5 Market opportunity by Product
	Exhibit 60: Market opportunity by Product ($ million)
	Exhibit 61: Data Table on Market opportunity by Product ($ million)
	8 Customer Landscape
	
	8.1 Customer landscape overview
	Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
	9 Geographic Landscape
	
	9.1 Geographic segmentation
	Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
	Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
	9.2 Geographic comparison
	Exhibit 65: Chart on Geographic comparison
	Exhibit 66: Data Table on Geographic comparison
	9.3 North America - Market size and forecast 2022-2027
	Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
	Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
	Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
	Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
	9.4 Europe - Market size and forecast 2022-2027
	Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
	Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
	Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
	Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
	9.5 Asia - Market size and forecast 2022-2027
	Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
	Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
	Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
	Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
	9.6 Rest of World (ROW) - Market size and forecast 2022-2027
	Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
	Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
	Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
	Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
	9.7 US - Market size and forecast 2022-2027
	Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
	Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
	Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
	Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
	9.8 Canada - Market size and forecast 2022-2027
	Exhibit 87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
	Exhibit 88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
	Exhibit 89: Chart on Canada - Year-over-year growth 2022-2027 (%)
	Exhibit 90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
	9.9 UK - Market size and forecast 2022-2027
	Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
	Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
	Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
	Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
	9.10 Germany - Market size and forecast 2022-2027
	Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
	Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
	Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
	Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
	9.11 China - Market size and forecast 2022-2027
	Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
	Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
	Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
	Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
	9.12 Market opportunity By Geographical Landscape
	Exhibit 103: Market opportunity By Geographical Landscape ($ million)
	Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
	10 Drivers, Challenges, and Trends
	
	10.1 Market drivers
	10.2 Market challenges
	10.3 Impact of drivers and challenges
	Exhibit 105: Impact of drivers and challenges in 2022 and 2027
	10.4 Market trends
	11 Vendor Landscape
	
	11.1 Overview
	11.2 Vendor landscape
	Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
	11.3 Landscape disruption
	Exhibit 107: Overview on factors of disruption
	11.4 Industry risks
	Exhibit 108: Impact of key risks on business
	12 Vendor Analysis
	
	12.1 Vendors covered
	Exhibit 109: Vendors covered
	12.2 Market positioning of vendors
	Exhibit 110: Matrix on vendor position and classification
	12.3 Apotex Inc.
	Exhibit 111: Apotex Inc. - Overview
	Exhibit 112: Apotex Inc. - Product / Service
	Exhibit 113: Apotex Inc. - Key offerings
	12.4 Aurobindo Pharma Ltd.
	Exhibit 114: Aurobindo Pharma Ltd. - Overview
	Exhibit 115: Aurobindo Pharma Ltd. - Product / Service
	Exhibit 116: Aurobindo Pharma Ltd. - Key offerings
	12.5 Bayer AG
	Exhibit 117: Bayer AG - Overview
	Exhibit 118: Bayer AG - Business segments
	Exhibit 119: Bayer AG - Key news
	Exhibit 120: Bayer AG - Key offerings
	Exhibit 121: Bayer AG - Segment focus
	12.6 Dr Reddys Laboratories Ltd.
	Exhibit 122: Dr Reddys Laboratories Ltd. - Overview
	Exhibit 123: Dr Reddys Laboratories Ltd. - Business segments
	Exhibit 124: Dr Reddys Laboratories Ltd. - Key offerings
	Exhibit 125: Dr Reddys Laboratories Ltd. - Segment focus
	12.7 Elam Pharma Pvt. Ltd.
	Exhibit 126: Elam Pharma Pvt. Ltd. - Overview
	Exhibit 127: Elam Pharma Pvt. Ltd. - Product / Service
	Exhibit 128: Elam Pharma Pvt. Ltd. - Key offerings
	12.8 Fresenius SE and Co. KGaA
	Exhibit 129: Fresenius SE and Co. KGaA - Overview
	Exhibit 130: Fresenius SE and Co. KGaA - Business segments
	Exhibit 131: Fresenius SE and Co. KGaA - Key news
	Exhibit 132: Fresenius SE and Co. KGaA - Key offerings
	Exhibit 133: Fresenius SE and Co. KGaA - Segment focus
	12.9 Glenmark Pharmaceuticals Ltd.
	Exhibit 134: Glenmark Pharmaceuticals Ltd. - Overview
	Exhibit 135: Glenmark Pharmaceuticals Ltd. - Product / Service
	Exhibit 136: Glenmark Pharmaceuticals Ltd. - Key offerings
	12.10 Hikma Pharmaceuticals Plc
	Exhibit 137: Hikma Pharmaceuticals Plc - Overview
	Exhibit 138: Hikma Pharmaceuticals Plc - Business segments
	Exhibit 139: Hikma Pharmaceuticals Plc - Key offerings
	Exhibit 140: Hikma Pharmaceuticals Plc - Segment focus
	12.11 Johnson and Johnson
	Exhibit 141: Johnson and Johnson - Overview
	Exhibit 142: Johnson and Johnson - Business segments
	Exhibit 143: Johnson and Johnson - Key news
	Exhibit 144: Johnson and Johnson - Key offerings
	Exhibit 145: Johnson and Johnson - Segment focus
	12.12 Novartis AG
	Exhibit 146: Novartis AG - Overview
	Exhibit 147: Novartis AG - Business segments
	Exhibit 148: Novartis AG - Key offerings
	Exhibit 149: Novartis AG - Segment focus
	12.13 Omega Laser Systems Ltd.
	Exhibit 150: Omega Laser Systems Ltd. - Overview
	Exhibit 151: Omega Laser Systems Ltd. - Product / Service
	Exhibit 152: Omega Laser Systems Ltd. - Key offerings
	12.14 Ozone Pharmaceuticals Ltd.
	Exhibit 153: Ozone Pharmaceuticals Ltd. - Overview
	Exhibit 154: Ozone Pharmaceuticals Ltd. - Key offerings
	12.15 Pfizer Inc.
	Exhibit 155: Pfizer Inc. - Overview
	Exhibit 156: Pfizer Inc. - Product / Service
	Exhibit 157: Pfizer Inc. - Key news
	Exhibit 158: Pfizer Inc. - Key offerings
	12.16 Teva Pharmaceutical Industries Ltd.
	Exhibit 159: Teva Pharmaceutical Industries Ltd. - Overview
	Exhibit 160: Teva Pharmaceutical Industries Ltd. - Business segments
	Exhibit 161: Teva Pharmaceutical Industries Ltd. - Key news
	Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key offerings
	Exhibit 163: Teva Pharmaceutical Industries Ltd. - Segment focus
	12.17 Viatris Inc.
	Exhibit 164: Viatris Inc. - Overview
	Exhibit 165: Viatris Inc. - Business segments
	Exhibit 166: Viatris Inc. - Key news
	Exhibit 167: Viatris Inc. - Key offerings
	Exhibit 168: Viatris Inc. - Segment focus
	13 Appendix
	
	13.1 Scope of the report
	13.2 Inclusions and exclusions checklist
	Exhibit 169: Inclusions checklist
	Exhibit 170: Exclusions checklist
	13.3 Currency conversion rates for US$
	Exhibit 171: Currency conversion rates for US$
	13.4 Research methodology
	Exhibit 172: Research methodology
	Exhibit 173: Validation techniques employed for market sizing
	Exhibit 174: Information sources
	13.5 List of abbreviations
	Exhibit 175: List of abbreviations
	Exhibits:
	
	Exhibits1: Executive Summary - Chart on Market Overview
	Exhibits2: Executive Summary - Data Table on Market Overview
	Exhibits3: Executive Summary - Chart on Global Market Characteristics
	Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
	Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
	Exhibits6: Executive Summary - Chart on Market Segmentation by Product
	Exhibits7: Executive Summary - Chart on Incremental Growth
	Exhibits8: Executive Summary - Data Table on Incremental Growth
	Exhibits9: Executive Summary - Chart on Vendor Market Positioning
	Exhibits10: Parent market
	Exhibits11: Market Characteristics
	Exhibits12: Offerings of vendors included in the market definition
	Exhibits13: Market segments
	Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
	Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
	Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
	Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
	Exhibits18: Historic Market Size - Data Table on global sciatica treatment market 2023-2027 2017 - 2021 ($ billion)
	Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
	Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
	Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
	Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
	Exhibits23: Five forces analysis - Comparison between 2022 and 2027
	Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
	Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
	Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
	Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
	Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
	Exhibits29: Chart on Market condition - Five forces 2022 and 2027
	Exhibits30: Chart on End-user - Market share 2022-2027 (%)
	Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
	Exhibits32: Chart on Comparison by End-user
	Exhibits33: Data Table on Comparison by End-user
	Exhibits34: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
	Exhibits35: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
	Exhibits36: Chart on Hospital - Year-over-year growth 2022-2027 (%)
	Exhibits37: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
	Exhibits38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
	Exhibits39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
	Exhibits40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
	Exhibits41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
	Exhibits42: Chart on Others - Market size and forecast 2022-2027 ($ million)
	Exhibits43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
	Exhibits44: Chart on Others - Year-over-year growth 2022-2027 (%)
	Exhibits45: Data Table on Others - Year-over-year growth 2022-2027 (%)
	Exhibits46: Market opportunity by End-user ($ million)
	Exhibits47: Data Table on Market opportunity by End-user ($ million)
	Exhibits48: Chart on Product - Market share 2022-2027 (%)
	Exhibits49: Data Table on Product - Market share 2022-2027 (%)
	Exhibits50: Chart on Comparison by Product
	Exhibits51: Data Table on Comparison by Product
	Exhibits52: Chart on Non-surgical treatment - Market size and forecast 2022-2027 ($ million)
	Exhibits53: Data Table on Non-surgical treatment - Market size and forecast 2022-2027 ($ million)
	Exhibits54: Chart on Non-surgical treatment - Year-over-year growth 2022-2027 (%)
	Exhibits55: Data Table on Non-surgical treatment - Year-over-year growth 2022-2027 (%)
	Exhibits56: Chart on Surgical treatment - Market size and forecast 2022-2027 ($ million)
	Exhibits57: Data Table on Surgical treatment - Market size and forecast 2022-2027 ($ million)
	Exhibits58: Chart on Surgical treatment - Year-over-year growth 2022-2027 (%)
	Exhibits59: Data Table on Surgical treatment - Year-over-year growth 2022-2027 (%)
	Exhibits60: Market opportunity by Product ($ million)
	Exhibits61: Data Table on Market opportunity by Product ($ million)
	Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
	Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
	Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
	Exhibits65: Chart on Geographic comparison
	Exhibits66: Data Table on Geographic comparison
	Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
	Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
	Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
	Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
	Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
	Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
	Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
	Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
	Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
	Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
	Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
	Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
	Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
	Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
	Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
	Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
	Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
	Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
	Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
	Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
	Exhibits87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
	Exhibits88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
	Exhibits89: Chart on Canada - Year-over-year growth 2022-2027 (%)
	Exhibits90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
	Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
	Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
	Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
	Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
	Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
	Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
	Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
	Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
	Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
	Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
	Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
	Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
	Exhibits103: Market opportunity By Geographical Landscape ($ million)
	Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
	Exhibits105: Impact of drivers and challenges in 2022 and 2027
	Exhibits106: Overview on Criticality of inputs and Factors of differentiation
	Exhibits107: Overview on factors of disruption
	Exhibits108: Impact of key risks on business
	Exhibits109: Vendors covered
	Exhibits110: Matrix on vendor position and classification
	Exhibits111: Apotex Inc. - Overview
	Exhibits112: Apotex Inc. - Product / Service
	Exhibits113: Apotex Inc. - Key offerings
	Exhibits114: Aurobindo Pharma Ltd. - Overview
	Exhibits115: Aurobindo Pharma Ltd. - Product / Service
	Exhibits116: Aurobindo Pharma Ltd. - Key offerings
	Exhibits117: Bayer AG - Overview
	Exhibits118: Bayer AG - Business segments
	Exhibits119: Bayer AG - Key news
	Exhibits120: Bayer AG - Key offerings
	Exhibits121: Bayer AG - Segment focus
	Exhibits122: Dr Reddys Laboratories Ltd. - Overview
	Exhibits123: Dr Reddys Laboratories Ltd. - Business segments
	Exhibits124: Dr Reddys Laboratories Ltd. - Key offerings
	Exhibits125: Dr Reddys Laboratories Ltd. - Segment focus
	Exhibits126: Elam Pharma Pvt. Ltd. - Overview
	Exhibits127: Elam Pharma Pvt. Ltd. - Product / Service
	Exhibits128: Elam Pharma Pvt. Ltd. - Key offerings
	Exhibits129: Fresenius SE and Co. KGaA - Overview
	Exhibits130: Fresenius SE and Co. KGaA - Business segments
	Exhibits131: Fresenius SE and Co. KGaA - Key news
	Exhibits132: Fresenius SE and Co. KGaA - Key offerings
	Exhibits133: Fresenius SE and Co. KGaA - Segment focus
	Exhibits134: Glenmark Pharmaceuticals Ltd. - Overview
	Exhibits135: Glenmark Pharmaceuticals Ltd. - Product / Service
	Exhibits136: Glenmark Pharmaceuticals Ltd. - Key offerings
	Exhibits137: Hikma Pharmaceuticals Plc - Overview
	Exhibits138: Hikma Pharmaceuticals Plc - Business segments
	Exhibits139: Hikma Pharmaceuticals Plc - Key offerings
	Exhibits140: Hikma Pharmaceuticals Plc - Segment focus
	Exhibits141: Johnson and Johnson - Overview
	Exhibits142: Johnson and Johnson - Business segments
	Exhibits143: Johnson and Johnson - Key news
	Exhibits144: Johnson and Johnson - Key offerings
	Exhibits145: Johnson and Johnson - Segment focus
	Exhibits146: Novartis AG - Overview
	Exhibits147: Novartis AG - Business segments
	Exhibits148: Novartis AG - Key offerings
	Exhibits149: Novartis AG - Segment focus
	Exhibits150: Omega Laser Systems Ltd. - Overview
	Exhibits151: Omega Laser Systems Ltd. - Product / Service
	Exhibits152: Omega Laser Systems Ltd. - Key offerings
	Exhibits153: Ozone Pharmaceuticals Ltd. - Overview
	Exhibits154: Ozone Pharmaceuticals Ltd. - Key offerings
	Exhibits155: Pfizer Inc. - Overview
	Exhibits156: Pfizer Inc. - Product / Service
	Exhibits157: Pfizer Inc. - Key news
	Exhibits158: Pfizer Inc. - Key offerings
	Exhibits159: Teva Pharmaceutical Industries Ltd. - Overview
	Exhibits160: Teva Pharmaceutical Industries Ltd. - Business segments
	Exhibits161: Teva Pharmaceutical Industries Ltd. - Key news
	Exhibits162: Teva Pharmaceutical Industries Ltd. - Key offerings
	Exhibits163: Teva Pharmaceutical Industries Ltd. - Segment focus
	Exhibits164: Viatris Inc. - Overview
	Exhibits165: Viatris Inc. - Business segments
	Exhibits166: Viatris Inc. - Key news
	Exhibits167: Viatris Inc. - Key offerings
	Exhibits168: Viatris Inc. - Segment focus
	Exhibits169: Inclusions checklist
	Exhibits170: Exclusions checklist
	Exhibits171: Currency conversion rates for US$
	Exhibits172: Research methodology
	Exhibits173: Validation techniques employed for market sizing
	Exhibits174: Information sources
	Exhibits175: List of abbreviations